Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2012 (2012), Article ID 431534, 6 pages
http://dx.doi.org/10.1155/2012/431534
Research Article

High-Resolution Genomic Profiling of Chromosomal Abnormalities in Human Stem Cells Using the 135 K StemArray

Ambry Genetics, Departments of Genomic Services and R&D, 15 Argonaut, Aliso Viejo, CA 92656, USA

Received 16 September 2011; Revised 6 February 2012; Accepted 6 February 2012

Academic Editor: Mohan C. Vemuri

Copyright © 2012 Aaron M. Elliott et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Maitra, D. E. Arking, N. Shivapurkar et al., “Genomic alterations in cultured human embryonic stem cells,” Nature Genetics, vol. 37, no. 10, pp. 1099–1103, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Spits, I. Mateizel, M. Geens et al., “Recurrent chromosomal abnormalities in human embryonic stem cells,” Nature Biotechnology, vol. 26, no. 12, pp. 1361–1363, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. S. M. Taapken, B. S. Nisler, M. A. Newton et al., “Karotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells,” Nature Biotechnology, vol. 29, no. 4, pp. 313–314, 2011. View at Publisher · View at Google Scholar
  4. Y. Mayshar, U. Ben-David, N. Lavon et al., “Identification and classification of chromosomal aberrations in human induced pluripotent stem cells,” Cell Stem Cell, vol. 7, no. 4, pp. 521–531, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Wu, K. J. Kim, K. Mehta et al., “Copy number variant analysis of human embryonic stem cells,” Stem Cells, vol. 26, no. 6, pp. 1484–1489, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Martins-Taylor, B. S. Nisler, S. M. Taapken et al., “Recurrent copy number variations in human induced pluripotent stem cells,” Nature Biotechnology, vol. 29, no. 6, pp. 488–491, 2011. View at Publisher · View at Google Scholar
  7. A. M. Elliott, K. A. Hohenstein Elliott, and A. Kammesheidt, “High resolution array-CGH characterization of human stem cells using a stem cell focused microarray,” Molecular Biotechnology, vol. 46, no. 3, pp. 234–242, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. R. R. Rao, J. D. Calhoun, X. Qin, R. Rekaya, J. K. Clark, and S. L. Stice, “Comparative transcriptional profiling of two human embryonic stem cell lines,” Biotechnology and Bioengineering, vol. 88, no. 3, pp. 273–286, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. S. S. L. Li, Y. H. Liu, C. N. Tseng, T. L. Chung, T. Y. Lee, and S. Singh, “Characterization and gene expression profiling of five new human embryonic stem cell lines derived in Taiwan,” Stem Cells and Development, vol. 15, no. 4, pp. 532–555, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Takahashi, K. Tanabe, M. Ohnuki et al., “Induction of pluripotent stem cells from adult human fibroblasts by defined factors,” Cell, vol. 131, no. 5, pp. 861–872, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Ramalho-Santos, S. Yoon, Y. Matsuzaki, R. C. Mulligan, and D. A. Melton, “‘Stemness’: transcriptional profiling of embryonic and adult stem cells,” Science, vol. 298, no. 5593, pp. 597–600, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Bortvin, K. Eggan, H. Skaletsky et al., “Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei,” Development, vol. 130, no. 8, pp. 1673–1680, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Maldonado-Saldivia, J. Van Den Bergen, M. Krouskos et al., “Dppa2 and Dppa4 are closely linked SAP motif genes restricted to pluripotent cells and the germ line,” Stem Cells, vol. 25, no. 1, pp. 19–28, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Madan, V. Madan, O. Weber et al., “The pluripotency-associated gene dppa4 is dispensable for embryonic stem cell identity and germ cell development but essential for embryogenesis,” Molecular and Cellular Biology, vol. 29, no. 11, pp. 3186–3203, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Du, T. Chen, X. Zou, B. Xiong, and G. Lu, “Dppa2 knockdown-induced differentiation and repressed proliferation of mouse embryonic stem cells,” Journal of Biochemistry, vol. 147, no. 2, pp. 265–271, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Ivanova, R. Dobrin, R. Lu et al., “Dissecting self-renewal in stem cells with RNA interference,” Nature, vol. 442, no. 7102, pp. 533–538, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Chakravarthy, B. Boer, M. Desler, S. K. Mallanna, T. W. Mckeithan, and A. Rizzino, “Identification of DPPA4 and other genes as putative Sox2:Oct-3/4 target genes using a combination of in silico analysis and transcription-based assays,” Journal of Cellular Physiology, vol. 216, no. 3, pp. 651–662, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. T. John, O. L. Caballero, S. J. Svobodová et al., “ECSA/DPPA2 is an embryo-cancer antigen that Is coexpressed with cancer-testis antigens in non-small cell lung cancer,” Clinical Cancer Research, vol. 14, no. 11, pp. 3291–3298, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. A. V. Andreeva and M. A. Kutuzov, “Cadherin 13 in cancer,” Genes Chromosomes and Cancer, vol. 49, no. 9, pp. 775–790, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Sato, Y. Mori, A. Sakurada, S. Fujimura, and A. Horii, “The H-cadherin (CDH13) gene is inactivated in human lung cancer,” Human Genetics, vol. 103, no. 1, pp. 96–101, 1998. View at Publisher · View at Google Scholar · View at Scopus
  21. Z. Y. Huang, Y. Wu, N. Hedrick, and D. H. Gutmann, “T-cadherin-mediated cell growth regulation involves G2 phase arrest and requires p21CIP1/WAF1 expression,” Molecular and Cellular Biology, vol. 23, no. 2, pp. 566–578, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. D. W. Chan, J. M. F. Lee, P. C. Y. Chan, and I. O. L. Ng, “Genetic and epigenetic inactivation of T-cadherin in human hepatocellular carcinoma cells,” International Journal of Cancer, vol. 123, no. 5, pp. 1043–1052, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Kawakami, J. Staub, W. Cliby, L. Hartmann, D. I. Smith, and V. Shridhar, “Involvement of H-cadherin (CDH13) on 16q in the region of frequent deletion in ovarian cancer,” International Journal of Oncology, vol. 15, no. 4, pp. 715–720, 1999. View at Google Scholar · View at Scopus
  24. S. Gustmann, L. Klein-Hitpass, H. Stephan et al., “Loss at chromosome arm 16q in retinoblastoma: confirmation of the association with diffuse vitreous seeding and refinement of the recurrently deleted region,” Genes Chromosomes and Cancer, vol. 50, no. 5, pp. 327–337, 2011. View at Publisher · View at Google Scholar
  25. D. E. C. Baker, N. J. Harrison, E. Maltby et al., “Adaptation to culture of human embryonic stem cells and oncogenesis in vivo,” Nature Biotechnology, vol. 25, no. 2, pp. 207–215, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Benezra, R. L. Davis, D. Lockshon, D. L. Turner, and H. Weintraub, “The protein Id: a negative regulator of helix-loop-helix DNA binding proteins,” Cell, vol. 61, no. 1, pp. 49–59, 1990. View at Publisher · View at Google Scholar · View at Scopus